Supported Research

Fanconi Anemia Type C Gene Therapy: Use of a HSV1/EBV Vector in Vitro and in Vivo Studies

2000 | Research Grant | UNC SCHOOL OF MEDICINE

Amount Funded: $62,042

Researchers: Jean-Michel Vos